You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Lysosomal Alpha Glucosidase Industry Research Report, Growth Trends and Competitive Analysis 2021-2027


The global Lysosomal Alpha Glucosidase market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Lysosomal Alpha Glucosidase production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Lysosomal Alpha Glucosidase by regions (countries) and by Application.
The global Lysosomal Alpha Glucosidase market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Lysosomal Alpha Glucosidase market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Lysosomal Alpha Glucosidase markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Lysosomal Alpha Glucosidase market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Lysosomal Alpha Glucosidase market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Lysosomal Alpha Glucosidase market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Lysosomal Alpha Glucosidase market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Lysosomal Alpha Glucosidase market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Lysosomal Alpha Glucosidase market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Lysosomal Alpha Glucosidase market by each application segment for the same period.
This report includes the following manufacturers:
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
Market Segment by Type
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
Market Segment by Application
Glycogen Storage Disease
Pompe Disease
Others
Research Methodology
To compile the detailed study of the global Lysosomal Alpha Glucosidase market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Lysosomal Alpha Glucosidase market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Lysosomal Alpha Glucosidase market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Type
1.2.2 AT-982
1.2.3 ATB-200
1.2.4 AVRRD-03
1.2.5 JR-162
1.2.6 MOSS-GAA
1.2.7 OXY-2810
1.2.8 Others
1.3 Market Segment by Application
1.3.1 Global Lysosomal Alpha Glucosidase Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Glycogen Storage Disease
1.3.3 Pompe Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Lysosomal Alpha Glucosidase Market Size (2016-2027)
2.1.1 Global Lysosomal Alpha Glucosidase Revenue (2016-2027)
2.1.2 Global Lysosomal Alpha Glucosidase Sales (2016-2027)
2.2 Global Lysosomal Alpha Glucosidase Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Lysosomal Alpha Glucosidase Sales by Regions (2016-2021)
2.2.2 Global Lysosomal Alpha Glucosidase Revenue by Regions (2016-2021)
2.3 Global Lysosomal Alpha Glucosidase Market Size Forecast by Region
2.3.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Region (2022-2027)
2.3.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Region (2022-2027)
2.4 Global Top Lysosomal Alpha Glucosidase Regions (Countries) Ranking by Market Size
2.5 Lysosomal Alpha Glucosidase Industry Trends
2.5.1 Lysosomal Alpha Glucosidase Market Trends
2.5.2 Lysosomal Alpha Glucosidase Market Drivers
2.5.3 Lysosomal Alpha Glucosidase Market Challenges
2.5.4 Lysosomal Alpha Glucosidase Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Lysosomal Alpha Glucosidase Manufacturers by Sales (2016-2021)
3.1.1 Global Lysosomal Alpha Glucosidase Sales by Manufacturers (2016-2021)
3.1.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Lysosomal Alpha Glucosidase Sales in 2020
3.2 Global Top Manufacturers Lysosomal Alpha Glucosidase by Revenue
3.2.1 Global Lysosomal Alpha Glucosidase Revenue by Manufacturers (2016-2021)
3.2.2 Top Lysosomal Alpha Glucosidase Manufacturers Covered: Ranking by Revenue
3.2.3 Global Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Lysosomal Alpha Glucosidase Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lysosomal Alpha Glucosidase as of 2020)
3.4 Global Lysosomal Alpha Glucosidase Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Lysosomal Alpha Glucosidase Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Lysosomal Alpha Glucosidase Market
3.7 Key Manufacturers Lysosomal Alpha Glucosidase Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Lysosomal Alpha Glucosidase Market Size by Type
4.1 Global Lysosomal Alpha Glucosidase Historic Market Review by Type (2016-2021)
4.1.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2016-2021)
4.1.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2016-2021)
4.1.3 Lysosomal Alpha Glucosidase Price by Type (2016-2021)
4.2 Global Lysosomal Alpha Glucosidase Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2022-2027)
4.2.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Type (2022-2027)
4.2.3 Lysosomal Alpha Glucosidase Price Forecast by Type (2022-2027)

5 Global Lysosomal Alpha Glucosidase Market Size by Application
5.1 Global Lysosomal Alpha Glucosidase Historic Market Review by Application (2016-2021)
5.1.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2016-2021)
5.1.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2016-2021)
5.1.3 Lysosomal Alpha Glucosidase Price by Application (2016-2021)
5.2 Global Lysosomal Alpha Glucosidase Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2022-2027)
5.2.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Application (2022-2027)
5.2.3 Lysosomal Alpha Glucosidase Price Forecast by Application (2022-2027)

6 North America
6.1 North America Lysosomal Alpha Glucosidase Sales Breakdown by Company
6.1.1 North America Lysosomal Alpha Glucosidase Sales by Company (2016-2027)
6.1.2 North America Lysosomal Alpha Glucosidase Revenue by Company (2016-2027)
6.2 North America Lysosomal Alpha Glucosidase Market Size by Type (2016-2027)
6.2.1 North America Lysosomal Alpha Glucosidase Sales by Type (2016-2027)
6.2.2 North America Lysosomal Alpha Glucosidase Revenue by Type (2016-2027)
6.3 North America Lysosomal Alpha Glucosidase Market Size by Application (2016-2027)
6.3.1 North America Lysosomal Alpha Glucosidase Sales by Application (2016-2027)
6.3.2 North America Lysosomal Alpha Glucosidase Revenue by Application (2016-2027)
6.4 North America Lysosomal Alpha Glucosidase Market Size by Country
6.4.1 North America Lysosomal Alpha Glucosidase Sales by Country (2016-2027)
6.4.2 North America Lysosomal Alpha Glucosidase Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Lysosomal Alpha Glucosidase Sales Breakdown by Company
7.1.1 Europe Lysosomal Alpha Glucosidase Sales by Company (2016-2027)
7.1.2 Europe Lysosomal Alpha Glucosidase Revenue by Company (2016-2027)
7.2 Europe Lysosomal Alpha Glucosidase Market Size by Type (2016-2027)
7.2.1 Europe Lysosomal Alpha Glucosidase Sales by Type (2016-2027)
7.2.2 Europe Lysosomal Alpha Glucosidase Revenue by Type (2016-2027)
7.3 Europe Lysosomal Alpha Glucosidase Market Size by Application (2016-2027)
7.3.1 Europe Lysosomal Alpha Glucosidase Sales by Application (2016-2027)
7.3.2 Europe Lysosomal Alpha Glucosidase Revenue by Application (2016-2027)
7.4 Europe Lysosomal Alpha Glucosidase Market Size by Country
7.4.1 Europe Lysosomal Alpha Glucosidase Sales by Country (2016-2027)
7.4.2 Europe Lysosomal Alpha Glucosidase Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Lysosomal Alpha Glucosidase Sales Breakdown by Company
8.1.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Company (2016-2027)
8.1.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Company (2016-2027)
8.2 Asia Pacific Lysosomal Alpha Glucosidase Market Size by Type (2016-2027)
8.2.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Type (2016-2027)
8.2.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Type (2016-2027)
8.3 Asia Pacific Lysosomal Alpha Glucosidase Market Size by Application (2016-2027)
8.3.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Application (2016-2027)
8.3.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Application (2016-2027)
8.4 Asia Pacific Lysosomal Alpha Glucosidase Market Size by Regions
8.4.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Regions
8.4.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Lysosomal Alpha Glucosidase Sales Breakdown by Company
9.1.1 Latin America Lysosomal Alpha Glucosidase Sales by Company (2016-2027)
9.1.2 Latin America Lysosomal Alpha Glucosidase Revenue by Company (2016-2027)
9.2 Latin America Lysosomal Alpha Glucosidase Market Size by Type (2016-2027)
9.2.1 Latin America Lysosomal Alpha Glucosidase Sales by Type (2016-2027)
9.2.2 Latin America Lysosomal Alpha Glucosidase Revenue by Type (2016-2027)
9.3 Latin America Lysosomal Alpha Glucosidase Market Size by Application (2016-2027)
9.3.1 Latin America Lysosomal Alpha Glucosidase Sales by Application (2016-2027)
9.3.2 Latin America Lysosomal Alpha Glucosidase Revenue by Application (2016-2027)
9.4 Latin America Lysosomal Alpha Glucosidase Market Size by Country
9.4.1 Latin America Lysosomal Alpha Glucosidase Sales by Country (2016-2027)
9.4.2 Latin America Lysosomal Alpha Glucosidase Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales Breakdown by Company
10.1.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Company (2016-2027)
10.1.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Company (2016-2027)
10.2 Middle East and Africa Lysosomal Alpha Glucosidase Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Type (2016-2027)
10.2.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Type (2016-2027)
10.3 Middle East and Africa Lysosomal Alpha Glucosidase Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Application (2016-2027)
10.3.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Application (2016-2027)
10.4 Middle East and Africa Lysosomal Alpha Glucosidase Market Size by Country
10.4.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Country (2016-2027)
10.4.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 Amicus Therapeutics Inc
11.1.1 Amicus Therapeutics Inc Corporation Information
11.1.2 Amicus Therapeutics Inc Overview
11.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Products and Services
11.1.5 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase SWOT Analysis
11.1.6 Amicus Therapeutics Inc Recent Developments
11.2 Audentes Therapeutics Inc
11.2.1 Audentes Therapeutics Inc Corporation Information
11.2.2 Audentes Therapeutics Inc Overview
11.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Products and Services
11.2.5 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase SWOT Analysis
11.2.6 Audentes Therapeutics Inc Recent Developments
11.3 Etubics Corp
11.3.1 Etubics Corp Corporation Information
11.3.2 Etubics Corp Overview
11.3.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Etubics Corp Lysosomal Alpha Glucosidase Products and Services
11.3.5 Etubics Corp Lysosomal Alpha Glucosidase SWOT Analysis
11.3.6 Etubics Corp Recent Developments
11.4 Genzyme Corp
11.4.1 Genzyme Corp Corporation Information
11.4.2 Genzyme Corp Overview
11.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Genzyme Corp Lysosomal Alpha Glucosidase Products and Services
11.4.5 Genzyme Corp Lysosomal Alpha Glucosidase SWOT Analysis
11.4.6 Genzyme Corp Recent Developments
11.5 greenovation Biotech GmbH
11.5.1 greenovation Biotech GmbH Corporation Information
11.5.2 greenovation Biotech GmbH Overview
11.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Products and Services
11.5.5 greenovation Biotech GmbH Lysosomal Alpha Glucosidase SWOT Analysis
11.5.6 greenovation Biotech GmbH Recent Developments
11.6 Huons Co Ltd
11.6.1 Huons Co Ltd Corporation Information
11.6.2 Huons Co Ltd Overview
11.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Huons Co Ltd Lysosomal Alpha Glucosidase Products and Services
11.6.5 Huons Co Ltd Lysosomal Alpha Glucosidase SWOT Analysis
11.6.6 Huons Co Ltd Recent Developments
11.7 JCR Pharmaceuticals Co Ltd
11.7.1 JCR Pharmaceuticals Co Ltd Corporation Information
11.7.2 JCR Pharmaceuticals Co Ltd Overview
11.7.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Products and Services
11.7.5 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase SWOT Analysis
11.7.6 JCR Pharmaceuticals Co Ltd Recent Developments
11.8 Oxyrane Belgium NV
11.8.1 Oxyrane Belgium NV Corporation Information
11.8.2 Oxyrane Belgium NV Overview
11.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Products and Services
11.8.5 Oxyrane Belgium NV Lysosomal Alpha Glucosidase SWOT Analysis
11.8.6 Oxyrane Belgium NV Recent Developments
11.9 Pharming Group NV
11.9.1 Pharming Group NV Corporation Information
11.9.2 Pharming Group NV Overview
11.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Pharming Group NV Lysosomal Alpha Glucosidase Products and Services
11.9.5 Pharming Group NV Lysosomal Alpha Glucosidase SWOT Analysis
11.9.6 Pharming Group NV Recent Developments
11.10 Sarepta Therapeutics Inc
11.10.1 Sarepta Therapeutics Inc Corporation Information
11.10.2 Sarepta Therapeutics Inc Overview
11.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Products and Services
11.10.5 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase SWOT Analysis
11.10.6 Sarepta Therapeutics Inc Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Lysosomal Alpha Glucosidase Value Chain Analysis
12.2 Lysosomal Alpha Glucosidase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lysosomal Alpha Glucosidase Production Mode & Process
12.4 Lysosomal Alpha Glucosidase Sales and Marketing
12.4.1 Lysosomal Alpha Glucosidase Sales Channels
12.4.2 Lysosomal Alpha Glucosidase Distributors
12.5 Lysosomal Alpha Glucosidase Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 130